Direct Molecular Detection and Genotyping ofBorrelia burgdorferi Sensu Latoin Cerebrospinal Fluid of Children with Lyme Neuroborreliosis
ABSTRACTThe current diagnostic marker of Lyme neuroborreliosis (LNB), theBorrelia burgdorferisensu latoantibody index (AI) in the cerebrospinal fluid (CSF), has insufficient sensitivity in the early phase of LNB. We aimed to elucidate the diagnostic value of PCR forB. burgdorferisensu latoin CSF from children with symptoms suggestive of LNB and to exploreB. burgdorferisensu latogenotypes associated with LNB in children. Children were prospectively included in predefined groups with a high or low likelihood of LNB based on diagnostic guidelines (LNB symptoms, CSF pleocytosis, andB. burgdorferisensu latoantibodies) or the detection of other causative agents. CSF samples were analyzed by twoB. burgdorferisensu lato-specific real-time PCR assays and, ifB. burgdorferisensu latoDNA was detected, were further analyzed by five singleplex real-time PCR assays for genotype determination. For children diagnosed as LNB patients (58 confirmed and 18 probable) (n= 76) or non-LNB controls (n= 28), the sensitivity and specificity of PCR forB. burgdorferisensu latoin CSF were 46% and 100%, respectively.B. burgdorferisensu latoDNA was detected in 26/58 (45%) children with AI-positive LNB and in 7/12 (58%) children with AI-negative LNB and symptoms of short duration. Among 36 children with detectableB. burgdorferisensu latoDNA, genotyping indicatedBorrelia garinii(n= 27) and non-B. garinii(n= 1) genotypes, while 8 samples remained untyped. Children with LNB caused byB. gariniidid not have a distinct clinical picture. The rate of detection ofB. burgdorferisensu latoDNA in the CSF of children with LNB was higher than that reported previously. PCR forB. burgdorferisensu latocould be a useful supplemental diagnostic tool in unconfirmed LNB cases with symptoms of short duration.B. gariniiwas the predominant genotype in children with LNB.